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Abstract 
 
Background/Aims: Mucinous gastric carcinoma (MGC) is a rare histopathological type of 
gastric carcinoma, for which the clinicopathological features and prognosis remain 
controversial. To clarify the clinical significance of mucinous histological type in gastric 
cancer, we studied clinicopathological characteristics of MGC tumors and prognosis of 
patients.  
Methodology: Forty-one patients with MGC and 1,407 patients with non-mucinous gastric 
carcinoma (NGC) were included in the study. Tumors were evaluated against patient gender 
and age, tumor location, size, and macroscopic type, depth of gastric wall invasion, lymph 
node metastasis, liver metastasis, peritoneal dissemination, distant metastasis, stage, and 
operative curability.  
Results: Compared with NGC tumors, MGC tumors were larger, showed more serosal 
invasion, were associated with a higher incidence of lymph node metastasis, and peritoneal 
dissemination, and tended to be at a more advanced stage. However, multivariate analysis 
demonstrated that the mucinous histological type was neither an independent prognostic factor 
nor an independent risk factor for lymph node metastasis in patients with gastric cancer.  
Conclusions: The mucinous histological type had no influence on patient outcome or the 
frequency of lymph node metastasis. MGC tumors are therefore biologically similar to those in 
NGC.  
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INTRODUCTION 
 
Mucinous gastric carcinoma (MGC) is a rare histopathological type of gastric tumors, 
comprising approximately 3-5% of gastric cancers (1-5). Mucinous gastric adenocarcinoma 
has been associated with a worse prognosis than the non-mucinous type (4), although other 
studies ruled out the mucinous histological classification as an independent prognostic factor in 
gastric cancer (1-3). Moreover, several groups have reported a higher frequency of lymph node 
metastasis with MGC than with non-mucinous gastric carcinoma (NGC) (2-4). To clarify 
clinical significance of this controversial mucinous histological type of gastric cancer, we 
studied the clinicopathological features of MGC tumors including predisposition to lymph 
node metastasis, as well as the prognosis of patients with MGC.  




A total of 1,448 Japanese patients with gastric cancer who underwent gastrectomy in the First 
Department of Surgery, Nagasaki University Hospital, from 1984 to 2004 were entered into 
this study. All specimens obtained from the patients were stained by hematoxylin-eosin and 
examined histopathologically. Informed consent was obtained from all patients. We defined 
MGC as a tumor in which more than 50% of the tumor area contained extracellular mucin 
pools, as described previously (2). Forty-one cases (2.8%) were classified as MGC, with the 
remaining cases classified as NGC. We examined patient gender and age, tumor location, size, 
and macroscopic type, depth of wall invasion, lymph node metastasis, liver metastasis, 
peritoneal dissemination, distant metastasis, as well as stage of the disease and operative 
curability. These clinicopathological findings were analyzed according to the Japanese 
classification system for gastric carcinoma outlined by the Japanese Gastric Cancer 
Association (6).  
Statistical Analysis 
Statistical analysis of the clinicopathological data was evaluated by the 2 test and 
Student’s t-test. Survival curves were calculated by the Kaplan-Meier method, and statistical 
differences were evaluated by log-rank tests. Prognostic factors were analyzed using the Cox 
proportional hazards model. Logistic regression analysis was used for a multivariate analysis 
of the risk factors for lymph node metastasis. A P value of <0.05 was considered to indicate a 
statistically significant difference. All statistical analyses were performed on a personal 
computer using StatView software (StatView, version 5.0J, SAS Institute Inc., NC). 
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RESULTS 
 
Table 1 lists the clinicopathological data for the 41 patients with MGC and 1,407 patients with 
NGC. There were no significance differences between MGC and NGC cases with respect to 
gender, age, tumor location, macroscopic type, metastasis to distant organs (including liver), 
and operative curability. Depth of wall invasion greater than T3 (tumor penetrates serosa) was 
found more frequently in MGC tumors than non-mucinous types (66% vs. 27%); one case of 
tumor invasion of the mucosa and two cases with tumor invasion of the submucosa were 
identified in T1 MGC. MGC tumors tended to be significantly larger in size than NGC tumors, 
as well as showing 
significantly more peritoneal dissemination, a higher incidence of lymph node metastasis, and 
appearing at a more advanced stage 
The overall survival rate was significantly lower in the MGC group than in those 
patients with NGC (Figure 1). However, when all patients were stratified according to depth of 
invasion, lymph node metastasis, and stage, there was no significant difference between the 
5-year survival rate of patients with MGC and NGC (Table 2). The Cox proportional hazards 
model was used to re-evaluate some of the clinicopathological parameters including patient 
gender and age, tumor location, tumor size, macroscopic and histological type of tumor, depth 
of gastric wall invasion, lymph node metastasis, and operative curability. Multivariate analysis 
identified tumor location, tumor size, depth of wall invasion, lymph node metastasis, and 
operative curability as significant independent prognostic factors in gastric cancer (Table 3). 
The histological classification of a gastric tumor as mucinous was not an independent 
prognostic factor for patients with gastric cancer in this study. 
To further assess whether the histological type of MGC was a predisposing factor for 
lymph node metastasis in gastric cancer, we analyzed the following factors by logistical 
regression: gender, age, tumor location, tumor size, macroscopic type, histological type, and 
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depth of tissue invasion. Multivariate analysis identified tumor size and depth of tumor 
invasion as the only significant independent factors associated with lymph node metastasis 
(Table 4). The mucinous histological type was not related to lymph node metastasis. 
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DISCUSSION 
 
MGC is a rare histological type constituting approximately 3% of gastric cancers (2-4). The 
prognosis of patients with MGC remains under discussion, with several studies finding a 
poorer prognosis for patients with MGC (4, 7-9), while others showing no significant 
prognostic difference between MGC and NGC cases (2, 10-12). The present study 
demonstrated a worse overall prognosis for patients with MGC compared with those with 
NGC; however, multivariate analysis indicated that a mucinous histological classification was 
not a significant independent prognostic factor. Previous comparisons of MGC with NGC 
ascribed the following clinicopathological features to MGC: larger tumor size (2-4, 7, 9, 11, 
13), higher position in stomach (2, 9), higher incidence of lymph node metastasis (2-4, 8, 9, 
11-14), more frequent serosal invasion (2, 3, 8, 9, 12), more extensive peritoneal dissemination 
(3, 4, 8, 11, 14), and more advanced in stage (2, 3, 9, 11, 12). Our study also demonstrated that 
the majority of diagnosed MGC cases were at an advanced stage. It is therefore possible that 
the poorer outcome of MGC patients was not associated with the mucinous histological type, 
but with the tumor stage at diagnosis. Only 0.4% of early-stage gastric cancers detected in this 
study were of a mucinous histological type. The reported frequencies of MGC among 
early-stage gastric cancers range from 0.7% to 9.2% (2, 3, 13, 15, 16), and it remains unclear 
why MGC is predominantly associated with cancers detected at a more advanced stage 
compared with other histological-type gastric carcinoma. Some hypotheses have been 
advocated as follows. MGC is thought to arise initially as a typical adenocarcinoma and then 
becomes mucinous during tumor progression. As the tumor invades the gastric wall, the 
intraluminal excretion of mucin decreases, leading to intramural mucin accumulation. MGC is 
located mainly in the submucosal or deeper gastric layer, and this also may also be explained 
by the intramural accumulation of mucin (16, 17). We identified only one tumor that showed 
mucosal invasion and two submucosal tumors in early MGC. This agrees with the findings of 
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Adachi et al. (13) that mucosal invasion of MGC (17%) was much less frequent than invasion 
of the submucosa (83%) in early-stage cancers, suggesting that reduced intraluminal excretion 
of mucin is accompanied by an increasing intraluminal accumulation of mucin during tumor 
invasion. 
Several studies have reported a higher frequency of lymph node metastasis with MGC 
than with NGC (2-4, 8, 9, 11-14). In particular, a stratified comparison according to depth of 
tumor invasion showed that lymph node metastasis in MGC was observed more frequently in 
patients with tumor invasion of at least the submucosal layer (4). Our results also demonstrated 
that MGC tumors were associated with a higher rate of lymph node metastasis than NGC 
tumors, but also implicated other clinicopathological factors as predisposing to lymph node 
metastasis, in addition to depth of tumor invasion. It remains unclear as to the significance of 
the mucinous histological type as a risk factor for lymph node metastasis in gastric cancer, 
although our regression analysis found no statistical evidence for such an association. In 
addition, Adachi et al. (13) reported no difference in the frequency of lymph node metastasis 
between early-stage MGC and early-stage NGC, further suggesting that a higher incidence of 
lymph node metastasis in MGC could be related to the extent of tumor invasion and tumor size 
rather than histological type. Therefore, the mere finding of a mucinous histological type does 
not present an extra risk factor for lymph node metastasis in gastric carcinoma. This finding has 
implications for the surgical treatment of patients with MGC regarding the need for extended 
lymph node dissection. 
 In conclusion, the histological classification of a gastric carcinoma as mucinous does 
not in itself have an impact on lymph node metastasis or prognosis in patients with MGC. 
Although mucinous gastric carcinoma tends to be more advanced in stage at diagnosis, the 
malignant potential of this tumor type is not different from that of non-mucinous gastric 
cancers.  
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TABLE 1 Clinicopathological Features of Mucinous Gastric Carcinoma and Non-mucinous 




n=41 (%) n=1407 (%) 
Gender    
Male 24 (59) 954 (68) NS 
Female 17 (41) 453 (32)  
Age    
(mean ± SD) (years) 60.9 ±11.2 63.1±11.6 NS 
Tumor location    
Upper 11 (27) 296 (21) NS 
Middle 16 (39) 566 (40)  
Lower 14 (34) 545 (39)  
Tumor size     
(mean ± SD) (mm) 74.2 ± 34.1 50.0 ± 38.0 <0.0001 
Macroscopic type    
Elevated 12 (29) 324 (23) NS 
Depressed 29 (71) 1083 (77)  
Depth of invasion    
T1 3 ( 7) 703 (50) <0.0001 
T2 11 (26) 328 (23)  
T3 22 (54) 256 (18)  
T4 5 (12) 120 ( 9)  
Lymph node metastasis    
Negative  13 (32) 838 (60) <0.001 
Positive 28 (68) 566 (40)  
Liver metastasis    
Negative  40 (98) 1357 (96) NS 
Positive 1 ( 2) 50 ( 4)  
Peritoneal 
dissemination    
Negative  32 (78) 1278 (91) <0.05 
Positive 9 (22) 129 ( 9)  
Distant organ metastasis    
Negative  41 (100) 1379 (98) NS 
Positive 0 ( 0) 28 ( 2)  
TNM classification     
Stage I 8 (20) 849 (60) <0.0001 
Stage II 10 (24) 174 (12)  
Stage III 16 (39) 226 (16)  
Stage IV 7 (17) 158 (11)  
Operative curability    
Curative 40 (98) 1357 (96) NS 
Noncurative 1 ( 2) 50 ( 4)  
MGC; mucinous gastric carcinoma, NGC: non-mucinous gastric carcinoma, NS; not 
significant, SD; standard deviation
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TABLE 2 Five-year Survival Rates of Patients with Mucinous Gastric Carcinoma and 
Non-mucinous Gastric Carcinoma 










Depth of invasion      
T1, T2 14 79.6 1028 88.9 NS 
T3, T4 27 40.2 369 26.2 NS 
Lymph node metastasis      
Negative  13 88.9 838 95.6 NS 
Positive 28 33.3 566 39.4 NS 
TNM classification      
Stage I, II 18 78.5 1023 90.5 NS 
Stage III, IV 23 31.5 387 23.5 NS 
 
MGC; mucinous gastric carcinoma, NGC: non-mucinous gastric carcinoma , NS; not 
significant 
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TABLE 3 Multivariate Analysis of Prognostic Factors in Patients with Gastric Carcinoma 
Variable Odds ratio (95%CI)* P value 
Gender   
Male 1  
Female 0.90 (0.71-1.14) 0.3772 
Age   
<65 years 1  
≥65 years 1.00 (0.80-1.25) 0.9867 
Tumor location   
Upper 1  
Middle 0.64 (0.48-0.86) 0.0028 
Lower 0.81 (0.62-1.06) 0.1229 
Tumor size (10mm) 10.06 (10.03-10.09) <0.0001 
Macroscopic type   
Elevated 1  
Depressed 1.10 (0.83-1.46) 0.5296 
Histopathological type   
NGC 1  
MGC 0.97 (0.56-1.67) 0.9052 
Depth of invasion   
T1, T2 1  
T3, T4 2.42 (1.83-3.20) <0.0001 
Lymph node metastasis   
Negative  1  
Positive 7.57 (5.01-11.43) <0.0001 
Operative curability   
Curative 1  
Noncurative 4.58 (3.53-5.95) <0.0001 
 
*CI; confidence interval, MGC; mucinous gastric carcinoma, NGC; non-mucinous gastric 
carcinoma 
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TABLE 4 Logistic Regression Analyses for Factors Associated with Lymph Node Metastasis 
in Gastric Carcinoma 
Variable Odds ratio (95%CI)* P value 
Gender   
Male 1  
Female 0.89 (0.67-1.19) 0.4391 
Age   
<65 years 1  
≥65 years 0.93 (0.71-1.23) 0.6191 
Tumor location   
Upper 1  
Middle 0.85 (0.59-1.22) 0.3642 
Lower 0.99 (0.69-1.43) 0.9582 
Tumor size    
<5cm  1  
≥5cm 4.54 (3.35-5.93) <0.0001 
Macroscopic type   
Elevated 1  
Depressed 1.28 (0.91-1.81) 0.1543 
Histopathological type   
NGC 1  
MGC 0.93 (0.40-2.14) 0.8562 
Depth of invasion   
T1, T2 1  
T3, T4 9.48 (6.75-13.51) <0.0001 
 
*CI; confidence interval, MGC; mucinous gastric carcinoma, NGC; non-mucinous gastric 
carcinoma 
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Figure Legends 
 
FIGURE 1 Overall Survival Curves for 1,448 Patients with Mucinous Gastric Carcinoma  and 
Non-mucinous Gastric Carcinoma  
 
 
